Safe and informed prescribing of psychotropic medication during the COVID-19 pandemic.

Jurjen J LuykxSisco M P van VeenArne RisseladaPaul NaardingJoeri K TijdinkChristiaan H Vinkers

Published in: The British journal of psychiatry : the journal of mental science (2020)

Treatment with psychotropic medication may sometimes be jeopardised because of the COVID-19 pandemic. One underlying reason is the lack of COVID-19-specific psychopharmacology guidelines. Here, we discuss five considerations arising from our clinical experience and pharmacological background knowledge to enable safe and well-informed psychopharmacotherapy during the COVID-19 pandemic.

Keyphrases

healthcare
adverse drug
coronavirus disease
sars cov
primary care
clinical practice
emergency department
combination therapy
drug induced